Development Agreements
Chemicals
Chemicals (5) | Development Agreements (659)
- American BriVision (Holding) Corp (1 contract)
- Crown Electrokinetics Corp. (2)
- NANOPHASE TECHNOLOGIES Corp (2)
- Clinical Development Service Agreement with Rgene (portions of the exhibit have been omitted because they (i) are not material and (ii) is the type of information that the... (American BriVision (Holding) Corp, Filed With SEC on June 21, 2022)
- Fourth Amendment to Intellectual Property Agreement, dated February 4, 2021, by and among Hewlett-Packard Development Company, L.P., HP, Inc. and Crown Electrokinetics Corp (Crown Electrokinetics Corp., Filed With SEC on February 10, 2021)
- Amendment #1, dated August 25, 2020, to the Amended and Restated Joint Development and Supply Agreement, dated May 15, 2018, between Solsence, LLC and Colorescience Inc. (portions... (NANOPHASE TECHNOLOGIES Corp, Filed With SEC on September 2, 2020)
- Joint Development Agreement, dated as of July 31, 2019, between the Company and Sumitomo Corporation of Americas (NANOPHASE TECHNOLOGIES Corp, Filed With SEC on August 2, 2019)
- Intellectual Property Agreement, dated as of January 31, 2016, between Hewlett-Packard Development Company, L.P. and 3D Nanocolor Corp. (and amendments thereto) (Crown Electrokinetics Corp., Filed With SEC on June 28, 2019)
